Biotechnology at Inter American University of Puerto Rico-Guayama

The initial earnings picture for biotechnology graduates looks promising, with first-year earnings around $47,000 based on national peer programs. However, there's a troubling disconnect here: by year four, actual reported earnings at this school drop to just $28,000—a significant decline rather than the growth you'd typically expect. That's $19,000 less than the initial estimate and raises questions about career trajectories for graduates from this specific program.

The estimated debt of $24,000 appears manageable against first-year projections, with a 0.51 ratio that would normally suggest reasonable returns. But against the actual fourth-year earnings of $28,000, that debt burden becomes more concerning. While Puerto Rico's biotechnology programs typically carry lower median debt ($13,779), graduates here appear to be taking on nearly double that amount. The school serves a predominantly Pell-eligible population (75%), making these debt levels particularly important to consider.

The real issue is uncertainty: with earnings estimated from national programs rather than actual outcomes from this school, and with reported four-year data showing a sharp earnings decline, it's difficult to confidently assess this program's value. If the $28,000 figure reflects typical mid-career earnings for this program's graduates, the investment becomes questionable. You need to understand why earnings might drop so dramatically and whether biotechnology graduates from this school are actually finding jobs in their field before committing.